Nashville, TN – RenalCare Options, LLC (“RCO”) is entering the renal care space under the name of New Renality with support from Zenyth Partners (“Zenyth”), an operationally-focused healthcare investment firm.
Founded by Chief Executive Officer Joseph Cashia, New Renality will break from the traditional fractured approach to patient care and follow the complete patient journey from diagnosis and beyond. By leveraging data-driven trends, the RCO integrated health model focuses on chronic disease management and early CKD intervention while reducing healthcare costs. Joe’s vision is shaped from 25+ years of experience in the healthcare industry. RCO strives to improve both quality of care and patient experience through innovative technologies and education to delay the progression of renal disease. When needed renal replacement therapy is available both in the comfort of the patient’s home or in one of the innovative New Renality patient-friendly clinics. RCO will utilize Zenyth’s capital to support its de novo clinic strategy as well as home health initiatives.
About the investment, Joe remarked “My team is excited to partner with Zenyth, a firm that has a proven track record of supporting their portfolio partners with not only capital but also deep operational expertise. This important milestone will allow RCO to roll out its home and clinic-based services to underserved markets in the Southeast.”
“We view Joe as a tremendous partner in this space. His track record over the past two plus decades in successfully building renal companies is second to none,” said Rob Feuer, Managing Partner, Zenyth Partners.
“Joe’s reputation among providers for emphasizing quality of care and an enhanced patient experience was very important to us as a firm,” added Sean Hayes, Partner, Zenyth Partners. “We believe that Joe’s approach to home dialysis and unique vision for dialysis clinics significantly differentiates RCO from the pack.”
RenalCare Options is the fourth foray for Joe in the renal space. Previously, he successfully founded and led National Renal Alliance, National Nephrology Associates, LLC and Renal Care Group.
Bass, Berry & Sims served as legal counsel to RenalCare Options, while Debevoise & Plimpton served as legal counsel to Zenyth Partners.
About RenalCare Options
Renal Care Options, LLC, parent company of New Renality, is a chronic and acute kidney disease management provider giving patients a better quality of life and reducing healthcare costs through innovative technologies, partnerships with local health care professionals and in-home therapy as a first option.
About Zenyth Partners
Zenyth Partners is an investment firm focused on building leading healthcare organizations. Zenyth has been active building healthcare businesses including The Smilist Management, Schweiger Dermatology Group, ReFocus Eye Health and RenalCare Options. Zenyth seeks to invest up to $35 million in each opportunity with the potential to invest more capital in the appropriate circumstances.